Impact on Cardiac Toxicity With Trastuzumab and Radiotherapy: The Question Is Still Ongoing
- 1 December 2009
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 27 (34), e239
- https://doi.org/10.1200/jco.2009.24.6918
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831Journal of Clinical Oncology, 2009
- Cardiovascular toxicity caused by cancer treatment: strategies for early detectionThe Lancet Oncology, 2009
- Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patientsRadiotherapy and Oncology, 2009
- “Therapy Insight: anthracyclines and trastuzumab—the optimal management of cardiotoxic side effects”Nature Clinical Practice Oncology, 2008